Background. Medication nonadherence is a frequent problem in the treatment of chronic conditions.
Introduction
Chronic nonmalignant pain is generally considered to last more than 6 months, is due to non-life-threatening causes, and may continue for the rest of the person's life [1] . Chronic nonmalignant pain is considered by many experts as a chronic disease in its own right, characterized by one or more of the following characteristics: it is permanent, leaves residual disability, is caused by nonreversible pathological alterations, requires special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care [2] .
Adherence is defined as the extent to which a person's behavior corresponds with the recommendations made by their health care provider [2] . The convention has been to define good adherence as carrying out 80% or more of the recommended behaviors (i.e., taking a prescribed medication) [3] . Medication nonadherence is a frequent problem in chronic conditions. In patients with chronic nonmalignant pain medication, nonadherence is a common problem and ranges from 8% to 53% [4, 5] .
There is a likely association between adherence to prescribed medication and chronic pain treatment outcomes. Stern et al. showed that pain intensity correlated negatively with analgesic adherence, and that intense pain predicted poor analgesic medication adherence [6] . Chronic pain management frequently requires treatment with opioids, and it has been shown that adherence monitoring is associated with 50% reduction in opioid abuse [7] and that monitoring of adherence early from the start of analgesic treatment may substantially reduce the costs associated with health issues incurred among nonadherent chronic pain patients, especially those treated with opioids [8] .
People over 65 make up a very important subgroup of patients because of population aging and associated health care expenditures [9] . A population-based study examining the use of medications among an adult ambulatory population revealed that more than 90% of women and men aged 65 years and older consumed medications, of whom 12% took at least 10 medications. Additionally, among people aged 65 and older, 19% of men and 23% of women took at least five prescription drugs [10] . Many elderly patients present with multiple chronic diseases, which require complex long-term treatment to prevent frailty and disability [2, [11] [12] [13] . The prevalence of cognitive and functional impairment in the elderly increases their risk of poor adherence. The study of Hayes et al. provided strong evidence that even very mild cognitive impairment in healthy elderly living independently in the community has a detrimental and significant impact on adherence to a medication regimen [14] .
Adherence is a multidimensional phenomenon, determined by various factors, where patient-related factors are just one determinant. Patient-related adherence factors include the resources, attitudes, beliefs, motivation, perceptions, and expectations of the patient. These include lack of perceived effect of treatment and negative beliefs regarding the treatment efficacy [15] . Studying the determinants of nonadherence is relevant as a first step toward adherence-enhancing interventions. However, studies that have focused on studying nonadherence in elderly patients and factors associated with nonadherence among older adults are scarce.
We hypothesized that nonadherence in patients with chronic nonmalignant pain aged Ն65 years is associated with pain diagnosis, lower socioeconomic status, polypharmacy, negative attitudes toward pain and analgesics, usage of alternative medicine, and higher pain intensity, and that the most common form of nonadherence is taking less medication than prescribed. Therefore, the goals of this study were to explore the prevalence of nonadherence to pharmacological treatment of nonmalignant chronic pain, types of nonadherence, association between nonadherence, and the number of medications prescribed to a patient, as well as patient factors and attitudes associated with nonadherence in individuals aged 65 and older.
Methods

Study Design
This was a cross-sectional study of 100 older patients who have been prescribed pharmacological treatment for chronic nonmalignant pain. Data on adherence, patient factors, and attitudes related to adherence were collected with a questionnaire; pain intensity was measured, and data on prescribed therapy were verified by reviewing patients' medical records. The study was approved by the Ethics Committee of the School of Medicine in Mostar, Bosnia and Herzegovina.
Setting
The study was conducted by five family medicine physicians of the Health Care Centre Mostar, Bosnia and Herzegovina between May 1, 2011 and October 1, 2011. The clinics where patients were recruited were general practices. A consecutive sampling design was used-all patients meeting the inclusion criteria during the study period were invited to participate.
Participants
Predefined inclusion criteria were as follows: citizens of Bosnia and Herzegovina, age Ն65 years, diagnosed with chronic nonmalignant pain lasting longer than 6 months, prescribed pharmacological pain treatment, and visited the Health Care Centre Mostar because of pain in 2011. Exclusion criteria were: dementia, malignant disease, and acute pain. Of the 107 older patients with chronic nonmalignant pain who visited participating institutions during the study period, five did not meet our inclusion criteria and two declined to participate in the study.
Seven study physicians screened the patients to determine whether they met the inclusion criteria, provided study information to eligible patients, and, after the patients consented, enrolled them in the study. Only the physician who collected the data was aware of the identity of the patients. Patient data were marked with a code, and anonymous patient data were delivered to the main researcher.
Pain Intensity
Before completing the questionnaires, the physicians measured patients' average pain intensity during the last month using a 0-10 visual analog scale (VAS). Patients were asked to place a mark on the line at a point that best represented their pain during the last month.
Questionnaire
A 37-item self-administered questionnaire consisted of five parts. The first part examined the socioeconomic characteristics of the patients, including age, gender, marital status, number of children, education level, number of household members, personal monthly income, and monthly household income. The second part inquired about condition-related variables-type and duration of chronic disease that causes pain and comorbidities. In the third part of the questionnaire, treatmentrelated variables were assessed: type and dose regimen of the prescribed therapy for the treatment of chronic nonmalignant pain and the number of prescription medications that a patient was taking for other medical conditions. We also analyzed the number and type of herbal and dietary supplements that the patients were taking for pain treatment.
Adherence to pharmacological treatment of nonmalignant pain was assessed in the fourth part of the questionnaire. Firstly, patients were asked "Do you take your analgesics exactly as a physician recommended at the time when the drug/s was/were prescribed?," requiring a simple yes or no answer. If the patients responded negatively, patients were asked how they actually took the drug, where response categories included-more often than prescribed, higher dose than prescribed, less often than prescribed, lower dose than prescribed, or changing frequency and dose depending on how he/she feels. The last response was supposed to capture the patients whose adherence behavior varied on different occasions. From these data, the underuse and overuse of analgesics were estimated.
To determine the degree of adherence to the prescribed analgesics, a four-item Morisky Medication Adherence Scale (MMAS-4) was used [16] . MMAS-4 consists of the following four questions: "Do you ever forget to take your medicine?," "Are you careless at times when taking your medicines?," "When you feel better, do you sometimes stop taking your medications?," and "Sometimes if you feel worse when you take your medicine, do you stop taking it?" Patients were instructed that these questions refer to their analgesics. The four MMAS items are answered either "Yes" or "No," where "Yes" was scored with one point and "No" with 0 points, so that the total score ranged from 0 to 4. The score was interpreted in this way: 0 = high level of adherence, 1-2 = moderate degree of adherence, 3-4 = low adherence. The Morisky scale assesses both intentional and unintentional nonadherence. The translation and use of the MMAS-4 were approved by the author and the owner of the copyrights, Professor Donald E. Morisky of the University of California, Los Angeles, School of Public Health. Translation and back-translation were performed according to the guidelines for the process of cross-cultural adaptation of selfreport measures [17] .
In the last part of the questionnaire, we examined respondents' attitudes about pain and analgesics, the tendency of patients to give their medication to others, and the tendency of patients to use alternative medicines. We used the 13-item Barriers Questionnaire (BQ-13) to measure patients' beliefs about pain and analgesics. BQ-13 was developed by Boyd-Seale et al. [18] , based on a 27-item Barriers Questionnaire of Ward et al. [19] . BQ-13 is sensitive to both intervention measures and sample differences [20] . BQ-13 covers the following domains: 1) fear of addiction; 2) medication tolerance; 3) fatalism; 4) desire to be a good patient; 5) disease progression; 6) fear of injections; 7) distracting the provider; and 8) medication side effects. Patients were asked to respond to each item measured with a 5-item Likert agree/disagree scale with neutral middle option (strongly disagree, disagree, neither agree nor disagree, agree, strongly agree). Data from the Likert-scaled items were further reduced by combining all agree and disagree responses into two categories.
Medical Records Data
Information on analgesics and other medications prescribed to each patient were collected from the patients' medical records, including data on the number, type, and dose of drugs.
Statistics
The sample size was calculated to detect a prevalence of nonadherence of 35% or higher, with a confidence interval of 95%, and an error of 10% (0.10). A total of 88 patients would be required, but we adjusted this upwards to 100 patients, in order to allow for missing data items. Anonymized patient data were entered into an electronic database. Descriptive statistics were expressed as frequencies and percentages or mean and standard deviation where appropriate. Differences between the groups of subjects (adherent/nonadherent) were calculated using Student's t-tests and c 2 tests. Phi and Cramer's V was used to express the relationship between categorical variables. Pearson point-biserial correlation coefficient (rpb) was used to express the relationship between the combinations of variables (one continuous and one categorical). Spearman's rank correlation coefficient (rs) was used for the asymmetrical variables.
Logistic regression analysis was employed to estimate the probability that a patient would be nonadherent with treatment. The predictor variables were the participant's pain reports, the number of all medications, the number of analgesics, reporting side effects, fear of addiction, and belief that sleepiness caused by analgesics is bothersome. Independent variables used in the model were chosen on the basis of the previously performed bivariate analyses, as well as scatterplots and correlations between variables that were examined before choosing the final predictive set. The main priority was to reduce the set of predictors as much as possible to avoid multicolinearity issues and to enable a concise interpretation of the model. The dependent variable used in the model was adherence (yes/no). Logistic regression provided information about the usefulness of the model. Some of those indicators are Cox and Snell's R Square and the Nagelkerke's R Square, whose values provide an indication of the amount of variation in the dependent variable explained by the model. All data analyses were performed using the statistical program SPSS 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Patient Characteristics
The study enrolled 100 patients with chronic nonmalignant pain. There were more women (N = 81) than men [19] . The mean age of the patients was 73 Ϯ 5.7 years. The majority of patients were married, had two children, and completed high school. The average number of household members was 2.4 Ϯ 1.4 ( Table 1) . Most of the participants indicated that their monthly household income was between 135 and 340 U.S. dollars.
Most (83%) patients had one diagnosis that was felt to be the cause of their chronic pain, while the rest had two such diagnoses ( Table 1 ). The most common diagnosis that caused chronic pain in study participants was spinal pain with or without radiculopathy. The largest number of patients had chronic pain for over 5 years (Table 1) . Patients reported a mean pain intensity of 6.6 Ϯ 2.2 on the VAS.
Patients took an average of 1.8 Ϯ 1.08 analgesics, including nonsteroidal anti-inflammatory drugs (NSAIDs) and opioid analgesics, as well as atypical analgesics. The most commonly taken NSAIDs were diclofenac (N = 46), acetaminophen (N = 23), and ibuprofen (N = 23). An opioid analgesic was prescribed to 10 patients, all of whom received weak opioid (tramadol). The most commonly prescribed atypical analgesics were corticosteroids (N = 12) and ketoprofen gel (N = 6).
Sixty-nine patients took prescription drugs for conditions other than chronic pain. The most common medications that the patients took for comorbidities were drugs affecting renal and cardiovascular function (N = 54), endocrine drugs (N = 19), drugs acting on the central nervous system (N = 7), drugs affecting gastrointenstinal function (N = 7), and drugs acting on the blood and the bloodforming organs (N = 7). There were nine patients who used herbal or dietary supplements: glucosamine and/or chondroitin sulphate (N = 5), ginkgo leaf extract (N = 2), valerian root extract (N = 1), and herbal preparations for the prostate (N = 1).
A majority (57%) of the patients said that they reported the side effects of pain medications to their doctor ( Table 2) . As many as 28% of patients indicated that they gave their analgesics to other people, including family (N = 21), neighbors (N = 9), and friends (N = 3). Alternative medicines for the treatment of chronic pain were used by 38% of patients, including various herbal and "natural" products.
Patient Adherence to Prescribed Analgesics for Nonmalignant Pain
To a direct question about the adherence to prescribed analgesics, 57% of patients responded that they did not take pain medication exactly as prescribed by their doctor. The most common deviation from the prescribed therapy for chronic pain was self-adjustment of the dose and frequency depending on the severity of pain and taking medication less often than it was prescribed by the physician (Table 2) .
On the Morisky scale, only 16% of patients expressed a high level of adherence to taking medication for chronic pain (a negative response to all four questions), while the medium level of adherence was reported by 43% of patients (an affirmative answer to one or two questions). Forty-one patients expressed low levels of adherence (41%) in the treatment of chronic pain, defined as an affirmative answer to three or four questions (Table 2) .
Unintentional nonadherence (a positive answer to the first two questions) was observed in 9% of patients, intentional nonadherence (a positive answer to the last two questions) was detected in 10% of patients, while 29% patients had a combination of both intentional and unintentional nonadherence.
We investigated whether there were differences between adherent and nonadherent patients in the studied variables, where adherence was defined with a response to the question "Do you take your analgesics exactly as a physician recommended at the time when the drug/s was/were prescribed?" The mean age of adherent patients was 72 Ϯ 5.6 years and 73 Ϯ 5.8 years for nonadherent patients. There was no significant betweengroup differences with respect to age (t = -0.60, P = 0.55). There was also no significant between-group differences with respect to gender (c 2 = 0.48, P = 0.49), marital status (c 2 = 4.12, P = 0.25), number of children (t = 0.14, P = 0.89), education (c 2 = 1.83, P = 0.77), number of household members (c 2 = 3.45, P = 0.75), personal income (c 2 = 2.75, P = 0.60), and household income (c 2 = 3.02, P = 0.40).
As we studied adherence in two ways, by a direct question on the use of analgesics exactly as prescribed, and also by using the Morisky scale, we examined whether there was an association between the patients' responses on the two measures. We found a statistically significant positive association between them (rpb = 0.49, P < 0.001).
None of the analyzed socioeconomic factors were significantly associated with adherence, regardless of the adherence measure. Also, we did not find any association between the various diagnoses causing chronic pain and patient adherence, regardless of the adherence measure. As 47 patients had spinal pain alone or in combination with other diagnoses, we analyzed whether this whole group of diagnoses was associated with adherence, but these analyses did not yield significant results using either adherence measure.
When the number of analgesics, number of other drugs, and the total number of prescribed medications that the patients were taking were analyzed in the context of patient adherence, we found that both measures of nonadherence (a negative answer to the question of taking medication as prescribed and the number of positive questions on the Morisky scale) were significantly associated with the number of analgesics taken by patients (correlation with the direct question: rpb = -0.32, P = 0.001, correlation with the Morisky scale: rs = 0.24, P = 0.01).
There was a significant correlation between the level of nonadherence on the Morisky scale and the use of alternative medicine (rpb = -0.29, P = 0.01). We also tested whether there was a link between the duration of chronic pain and adherence, but we did not find an association for the direct question (V = 0.24, P = 0.07) or for the Morisky scale (r = -0.15, P = 0.15).
Nonadherence was significantly associated with giving painkillers to other people for the direct question on adherence (Phi = -0.28, P = 0.007), but not for the Morisky scale as well (rpb = -0.104, P = 0.301).
Beliefs about Pain and Pain Therapy
Most patients (59%) agreed that the presence of pain meant that the disease was getting worse, and nearly half of all patients (48%) indicated that people could easily become addicted to pain medication. The majority of study participants disagreed with the statement that the side effects of analgesics were unbearable (Table 3) .
In order to fully assess the impact of a number of factors on the likelihood that respondents would be adherent vs nonadherent with their treatment, a logistic regression analysis was performed. The model contained six independent variables (pain intensity VAS results, total number of medications used, total number of analgesics used, the tendency to report side effects, fear of addiction, and belief that sleepiness caused by analgesics is bothersome). The full model containing all the predictors was statistically significant c 2 (6,100) = 54.24, P < 0.001, indicating that the model was able to distinguish between adherent (vs nonadherent) patients. The model as a whole explained between 47.2% and 63.4% of the variance in adherence and correctly classified 87.1% of cases. As shown in Table 4 , six independent variables made a unique statistically significant contribution to the model. Not reporting side effects and the lack of fear of addiction were the strongest predictors of adherence measured with the direct question. The reporting side effects predictor was found to have an odds ratio of 17.51, indicating that patients who tended to report all side effects were 18 times more likely to be adherent with their medication as compared with those who did not report experiencing side effects. The odds ratio for fear of addiction was 13.49, indicating that those who were less anxious about addiction were 14 times more likely to be adherent (Table 4) . Other predictors of adherence were the lack of belief that sleepiness caused by analgesics is bothersome, number of analgesics lower than three, pain intensity on VAS lower than five, and number of all medications lower than five (Table 4) .
Discussion
In this study on adherence to pharmacological therapy prescribed for chronic nonmalignant pain in patients aged 65 and older, 57% of patients indicated that they did not take prescribed analgesics exactly as the physician recommended, while 84% exhibited some form of nonadherence on the Morisky scale, a self-report measure of medication-taking behavior.
In a meta-analysis of 569 studies, DiMatteo showed that the average medication nonadherence rate in various age cohorts and across different diseases was 25% [21] . A meta-analysis examining medication adherence rates across diseases in the older showed that 29-59% of outpatients do not take their medications as prescribed [22] . An explanation for the high rate of nonderadherence that we observed might be that chronic nonmalignant pain is a chronic condition, but not a life-threatening one, and patients may feel that not taking their medication will not have an immediate effect on disease outcomes [4] . A meta-analysis across 27 studies including different ages and medical conditions showed a strongly positive relationship between patients' compliance and their perception of disease severity [23] .
In our study, nonadherence, as measured with the Morisky scale, was higher than in previous studies on adherence in the general population [21, 22] . This could be due to the older population that was studied, but also due to the fact that the study was conducted in a postwar area. War has also been reported to have an influence on adherence to therapies, even after the war is over [24] . This may be the result of war experiences such as economic hardship, lack of medical control, fatalism, and anarchy [24] .
The most common deviation from the prescribed therapy in our study was self-adjustment of the dose and frequency of drug taking based on the severity of pain, and the second most common deviation was underuse of the prescribed analgesics. Previous studies found that the most common form of nonadherence regarding chronic nonmalignant pain treatment was underuse [4, 5, 25] . However, these studies did not explore the older population exclusively. In a study of older patients with osteoarthritis, it was also found that the most common deviation from taking pain prescriptions as prescribed was taking them less frequently and in smaller doses [26] .
Patients' overusing their prescribed medication (especially opioids) is one of the fears of physicians when making decisions about the treatment of pain. In a multicenter study, Broekmans et al. found that the most frequently overused analgesics were opioids (58%), followed by nonopioid (19%) and atypical analgesics (11%), while 11% of overusers overused more than one type of analgesic [5] . Adherence monitoring, including controlled substance agreements and various periodic measures of adherence, was associated with a 50% reduction in opioid abuse [7] . Interventions such as urine drug monitoring are available for monitoring adherence, and recommendations for its implementation in chronic pain patients have been published [27] .
Nonadherence may be unintentional or intentional. We found that 9% of patients reported unintentional nonadherence, 10 reported intentional nonadherence, and 29 reported a combination of both. The previous multicenter study of younger patients with chronic nonmalignant pain found that 38% of the patients were unintentionally nonadherent, and 63% were intentionally nonadherent [5] .
Our study indicates that nonadherent patients were more likely to give their prescription analgesics to other people as compared with those who were adherent. Adherence was significantly associated with using analgesics for the prescribed diagnosis and reporting of side effects. Both the higher number of prescribed analgesics and the total number of prescribed medications (analgesics and nonanalgesics) were positively associated with the two measures of nonadherence. An association between the number of drugs and adherence has been previously described in an older population [28] .
Our patients reported a rather high mean pain intensity of 6.6 Ϯ 2.2 on the VAS. Undertreatment of pain is common, and the recommended treatment is usually not in accordance with clinical guidelines [29] [30] [31] . In a study of de Wit et al., it was found that 60% of hospital patients were treated inadequately for their pain [32] . In a study of patients with neuropathic pain, 73% of individuals complained of inadequate pain control, 25% had never tried (either in the past or at the time of research) any antineuropathic analgesics (e.g., tricyclic antidepressants, opioids, or anticonvulsant), and new antineuropathic analgesics (e.g., gabapentin) were being used only by 17% [33] . Only 10% of patients in our study received opioids, and in all cases, the weak opioid tramadol was used.
Our study did not find an association between adherence and pain-causing diagnoses, pain duration, and pain intensity. In previous studies, Berndt et al. did not find a correlation between adherence and pain intensity [34] , but Stern et al. found a negative correlation between pain intensity and analgesic adherence [6] . Previous studies have shown that patients who experience a higher pain intensity or patients in poorer health are more likely to be adherent [5, 23, 25] .
The use of alternative medicine was significantly associated with nonadherence exhibited on the Morisky scale. In patients with cancer, it was found that individuals interested in or using complementary and alternative medicine did not show more psychological disturbance, poorer social support, or less trust in medicine or compliance with radiotherapy than subjects without such an interest [35] .
Regarding patients' beliefs and adherence, we found that the majority of participants believed that higher pain intensity indicated disease progression, and half of the participants believed that one could easily become addicted to pain medications. Fear of addiction also proved to be the strongest predictor of adherence, indicating that the less anxious patients were about the possibility of addiction caused by their analgesic medication use, the more likely they were to adhere with the prescribed treatment. It has been previously shown that patients' concerns about medication use predicts nonadherence, and if the patients perceived the benefits of taking pain medication as high, they are more willing to risk experiencing bothersome side effects [36] [37] [38] [39] [40] [41] . Gilron et al. found that fears of addiction and side effects were expressed by 32% and 48% of patients with neuropathic pain [33] .
In this study, we explored patient-related factors of adherence, but other factors that may influence adherence are social and economic factors, as well as factors related to the health care team and system, condition, and therapy. Considering there are a number of factors that influence adherence, nonadherent patients should be supported, not blamed [15] . Furthermore, it has been shown that patients with chronic physical illness engage in an implicit cost-benefit analysis in which they weigh their beliefs about the necessity of the prescribed medication against their concerns about the potential adverse effects, and that these beliefs are related to medication adherence [42] . Adherence, thus, may be a reasoned decision made by patients [43] .
Sale et al. studied adherence to pain medication among older adults with osteoarthritis aged 67-92 and found that the patients' perceptions and behaviors toward pain medication differed when compared with their use of nonanalgesic medications. Patients purposefully took analgesics in lower doses and less frequently than recommended, but they were generally adherent to their other medications. This study revealed that individuals may have clearly articulated reasons for altering their pain medication regime, including fear of addiction and reducing the number of pills taken daily. Even though pain limited the daily activities of the patients, most participants did not consider their pain strong enough to take prescribed analgesics [26] .
The patients' perceptions of the treatment efficacy may be influenced by disease-specific beliefs. Believing that pain is a natural part of growing old, that patients should expect to live with their pain during aging, and accept it instead of treat it [44, 45] may also influence adherence.
Physicians may find ways to explore the beliefs and behaviors of older patients related to adherence to pain medication and use them to set common treatment goals. By involving a patient in the decision-making process, the patient becomes a partner, and the treatment goal will not be defined only by overly narrow biomedical goals [46] . Shared decision making may have a beneficial effect on patient satisfaction, treatment adherence, and health status, especially when a patient has a chronic illness [47] .
There is no gold standard for measuring adherence [48] .
The most simple approach is ascertaining patients' selfreport, i.e., asking patients directly for their subjective ratings of adherence behavior or measuring adherence with standardized questionnaires such as the MMAS-4 [16] . Furthermore, adherence may be assessed via direct medication measurement (pill count), use of electronic monitoring devices, biochemical measurement of drug concentrations in blood or urine, and review of pharmacy databases for prescription records. These more complex measures are costly or depend on information technology [48] . If there are no resources for more sophisticated adherence measures, we recommend that clinicians use self-report screening for nonadherence during routine office visits.
A limitation of our study was a dichotomous use of nonadherence for analysis. We found five different types of nonadherence, including using medications more frequently, less frequently, in a higher or lower dose, or depending on the severity of pain. Some of these patient groups were small, which could bias the statistical analysis, and therefore, we decided to analyze adherence as a dichotomous measure. Furthermore, in our study, the participants were recruited directly by the researching physician whose advice they were expected to follow. This bias could lead participants to report more positively about their adherence. As the prevalence of nonadherence was very high in this study, we believe that this potential bias did not influence the results.
In conclusion, high pain intensity and nonadherence to analgesic therapy in older patients with chronic nonmalignant pain found in this study suggest that physicians should try to monitor their patients more closely to ensure better adherence to pharmacological therapy. Physicians should also address patients' beliefs regarding analgesics associated with nonadherence.
